ACURX PHARMACEUTICALS INC's ticker is ACXP and the CUSIP is 00510M104. A total of 13 filers reported holding ACURX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $750,000 | -76.1% | 500,000 | -57.7% | 0.01% | -75.6% |
| Q2 2023 | $3,132,300 | +223.3% | 1,182,000 | +322.1% | 0.04% | +221.4% |
| Q1 2023 | $968,800 | -72.3% | 280,000 | -68.2% | 0.01% | -77.0% |
| Q4 2022 | $3,502,400 | +9.5% | 880,000 | -17.4% | 0.06% | +10.9% |
| Q3 2022 | $3,198,000 | – | 1,066,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Draper Asset Management, LLC | 266,025 | $1,058,780 | 1.47% |
| ARMISTICE CAPITAL, LLC | 880,000 | $3,502,400 | 0.06% |
| Semmax Financial Advisors Inc. | 5,879 | $24 | 0.01% |
| Belpointe Asset Management LLC | 3,000 | $11,940 | 0.00% |
| TD Waterhouse Canada Inc. | 18,656 | $77,422 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 10,100 | $40,198 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 77,283 | $307 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 29,096 | $116 | 0.00% |
| BlackRock Inc. | 15,639 | $62,243 | 0.00% |